Coordinated both CONCERT (EUR 2.9M) and RadoNorm (EUR 3.2M), two large-scale European joint programmes on radiation exposure, dosimetry, and risk assessment.
BUNDESAMT FUER STRAHLENSCHUTZ
Germany's federal radiation protection authority, coordinating pan-European research on dosimetry, medical radiation safety, and exposure risk assessment.
Their core work
The Bundesamt für Strahlenschutz (BfS) is Germany's Federal Office for Radiation Protection, the national authority responsible for protecting people and the environment from ionising and non-ionising radiation. Their work spans radiation dosimetry, risk assessment, nuclear safety regulation, and medical radiation protection across therapy, nuclear medicine, and radiology. In H2020, they coordinated major European efforts to integrate radiation protection research and establish evidence-based exposure standards, while also contributing to nuclear education frameworks and medical radiation safety roadmaps.
What they specialise in
RadoNorm focuses on exposure and dosimetry, while CONCERT integrated radiation protection research across Europe — both areas where BfS leads as national authority.
Participated in EURAMED rocc-n-roll, developing a strategic research agenda for medical applications of ionising radiation including radiation therapy, nuclear medicine, and radiology.
Contributed to ANNETTE, which developed advanced networking for nuclear education including ECVET frameworks, advanced master programmes, and continuous professional development.
RadoNorm explicitly addresses societal aspects and communication-dissemination alongside technical dosimetry, signalling growing emphasis on public engagement with radiation science.
How they've shifted over time
BfS's early H2020 involvement (2015-2016) centred on nuclear education infrastructure — professional training networks, ECVET mobility frameworks, and summer courses through ANNETTE, alongside launching the broad CONCERT joint programme. By 2020, their focus shifted decisively toward applied radiation protection: medical radiation safety (EURAMED rocc-n-roll) and evidence-based exposure standards with strong societal dimensions (RadoNorm). The evolution shows a move from education and capacity-building toward front-line scientific evidence production and public-facing radiation risk communication.
BfS is moving toward integrating societal and public communication dimensions into technical radiation protection research, making them an increasingly relevant partner for projects that bridge science and policy.
How they like to work
BfS operates as a consortium leader in large-scale European joint programmes — both their coordinated projects (CONCERT, RadoNorm) carry multi-million euro budgets and involve extensive partner networks. With 150 unique partners across 30 countries, they function as a major hub in European radiation protection research. Their balanced 50/50 split between coordinator and participant roles, combined with their national authority status, means they bring both scientific credibility and administrative capacity to any consortium.
BfS has built an exceptionally broad network of 150 unique consortium partners spanning 30 countries, driven largely by their coordination of two major European joint programmes. This reach is pan-European and reflects their role as a central node in the radiation protection research community.
What sets them apart
As Germany's national radiation protection authority, BfS occupies a rare position at the intersection of regulatory mandate, scientific research, and European policy coordination. Unlike university research groups, they bring regulatory authority and direct policy influence to their projects. Their ability to coordinate 150+ partners across 30 countries in joint programmes makes them one of the most connected organisations in European radiation protection — an essential partner for any consortium that needs credibility with both scientists and regulators.
Highlights from their portfolio
- RadoNormTheir largest project (EUR 3.2M as coordinator), combining technical dosimetry with societal aspects of radiation risk — represents their current strategic direction through 2025.
- CONCERTA European Joint Programme (EUR 2.9M as coordinator) that integrated radiation protection research across the continent, demonstrating BfS's capacity to lead large-scale cross-border scientific coordination.
- EURAMED rocc-n-rollPositions BfS in the medical radiation space with a strategic research agenda spanning radiation therapy, nuclear medicine, and radiology — a significant expansion beyond their traditional environmental/occupational focus.